EDGE THERAPEUTICS INC's ticker is EDGE and the CUSIP is 279870109. A total of 46 filers reported holding EDGE THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $109,000 | -60.9% | 338,961 | -0.1% | 0.00% | – |
| Q3 2018 | $279,000 | -19.6% | 339,336 | +0.7% | 0.00% | – |
| Q2 2018 | $347,000 | -75.0% | 337,073 | -71.4% | 0.00% | – |
| Q1 2018 | $1,389,000 | -84.3% | 1,177,470 | +24.5% | 0.00% | – |
| Q4 2017 | $8,863,000 | -11.6% | 945,842 | +1.3% | 0.00% | -100.0% |
| Q3 2017 | $10,022,000 | +9.5% | 934,006 | +4.7% | 0.00% | – |
| Q2 2017 | $9,151,000 | +36.6% | 891,872 | +21.3% | 0.00% | – |
| Q1 2017 | $6,698,000 | +26692.0% | 735,332 | +36944.4% | 0.00% | – |
| Q4 2016 | $25,000 | -62.1% | 1,985 | -68.8% | 0.00% | – |
| Q3 2016 | $66,000 | +3.1% | 6,354 | 0.0% | 0.00% | – |
| Q2 2016 | $64,000 | +6300.0% | 6,354 | +5024.2% | 0.00% | – |
| Q1 2016 | $1,000 | – | 124 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 2,344,868 | $24,058,000 | 16.90% |
| VHCP Management II, LLC | 1,933,582 | $19,839,000 | 7.92% |
| ACUTA CAPITAL PARTNERS, LLC | 1,504,612 | $15,437,000 | 4.32% |
| Opaleye Management Inc. | 130,000 | $1,334,000 | 0.56% |
| SPHERA FUNDS MANAGEMENT LTD. | 150,000 | $1,539,000 | 0.26% |
| DAFNA Capital Management LLC | 19,400 | $199,000 | 0.14% |
| REGENTATLANTIC CAPITAL LLC | 134,900 | $1,384,000 | 0.13% |
| MARK SHEPTOFF FINANCIAL PLANNING, LLC | 14,400 | $148,000 | 0.10% |
| TFS CAPITAL LLC | 20,080 | $206,000 | 0.08% |
| EAGLE ASSET MANAGEMENT INC | 901,359 | $9,247,000 | 0.06% |